Related Experiment Videos

Thrombolytic therapy in acute myocardial infarction in Pakistan

M A Karim1, S F Mahmood, J Akhter

  • 1Department of Medicine, University of Nebraska Medical Center, Omaha, USA.

Insights

This study on acute myocardial infarction (AMI) in Pakistan found males were more affected, but women had more complications. Thrombolysis with streptokinase significantly reduced mortality in AMI patients.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Acute myocardial infarction (AMI) poses a significant health challenge globally.
  • Characterizing AMI features in specific populations is crucial for targeted interventions.
  • The role of thrombolysis in managing AMI in Pakistan requires further investigation.

Purpose of the Study:

  • To define the clinical characteristics of AMI in a Pakistani cohort.
  • To evaluate the effectiveness of thrombolysis, specifically streptokinase, in reducing mortality from AMI in Pakistan.

Main Methods:

  • A study of 194 consecutive patients admitted with enzyme-positive AMI.
  • Data collection included patient demographics, clinical presentation, complications, and treatment received.
  • Statistical analysis was performed to compare outcomes between patients who received streptokinase and those who did not.

Main Results:

  • Males were three times more frequently affected by AMI than females.
  • Women experienced a higher incidence of complications despite lower overall frequency.
  • Anterior wall myocardial infarction was unusually common (39%), and LV failure was a predominant complication.
  • Cardiogenic shock was associated with over 93% mortality.
  • Streptokinase administration in 60% of patients with transmural AMI led to a statistically significant reduction in mortality (15.2% vs. 24.7%, p < 0.05).

Conclusions:

  • AMI in Pakistan presents with distinct features, including a high rate of anterior wall infarction and significant complications in women.
  • Thrombolysis with streptokinase demonstrates a significant benefit in reducing mortality in Pakistani patients with AMI.
  • Further research and implementation of thrombolytic therapy are warranted to improve outcomes for AMI in Pakistan.

Related Concept Videos